Пошуковий запит: (<.>U=Р569.413$<.>) |
Загальна кількість знайдених документів : 284
Представлено документи з 1 до 20
|
| | |
| 1. |
Horbay R. O. A comparison of paclitaxel and vinblastine induced giant cell formation in murine NK/Ly lymphoma // Біол. студії. - 2011. - 5, № 1.
|
| 2. |
Renouf B. Activation of p53 by MDM2 antagonists has differential apoptotic effects on EBV-positive and EBV-negative Burkitt's lymphoma cells // Biopolymers and Cell. - 2009. - 25, № 4.
|
| 3. |
Бутенко А. К. Application of recombinant interferons in treatment of malignant lymphomas and leukemias . — 1998 // Эксперим. онкология.
|
| 4. |
Valadbeigi S. Assessment of trace elements in serum of acute lymphoblastic and myeloid leukemia patients // Experimental Oncology. - 2019. - 41, № 1.
|
| 5. |
Fusun T. Association of HER-2/neu overexpression with the number of involved axillary lymph nodes in hormone receptor positive breast cancer patients. — 2005 // Эксперим. онкология.
|
| 6. |
Utkan G. Blood viscosity in patients with diffuse large B cell non-Hodgkin's lymphoma. — 2006 // Эксперим. онкология.
|
| 7. |
Camara-Clayette V. BMP7 is involved in Mantle cell lymphoma secondary drug resistance // Biopolymers and Cell. - 2009. - 25, № 4.
|
| 8. |
Maznyk N. A. Calibration dose-response relationships for cytogenetic biodosimetry of recent and past exposure to low dose gamma-radiation. — 2004 // Укр. радіол. журн.
|
| 9. |
Yurchenko M. CD150-mediated Akt signalling pathway in normal and malignant B cells // Эксперим. онкология. - 2011. - 33, № 1.
|
| 10. |
Yurchenko M. Yu. CD150-mediated signaling pathways in Hodgkin's disease cell lines // Укр. біохім. журн.. - 2005. - 77, № 2 [спец. вип.].
|
| 11. |
Sheng Zhang CD4+ T cells tumor specific response exists in L615 leukemia mice: adoptive transfer in combination with cyclophosphamide. — 2004 // Эксперим. онкология.
|
| 12. |
Соколовская А. А. CD95-A дефицитные клетки сублинии Jurkat/A4, устойчивые к лекарственно-индуцированному апоптозу. — 2001 // Эксперим. онкология.
|
| 13. |
Konac E. Detection of <$E bold p53> deletions using FISH technique in the HL-60, Daudi, Raji and K-562 cell lines. — 2003 // Эксперим. онкология.
|
| 14. |
Shalai Ya. R. Effect of novel 2-amino-5-benzylthiazole derivative on cellular ultrastructure and activity of antioxidant system in murine lymphoma cells // Біол. студії. - 2019. - 13, № 1.
|
| 15. |
Shalai Ya. R. Effect of novel 2-amino-5-benzylthiazole derivative on cellular ultrastructure and activity of antioxidant system in murine lymphoma cells // Біол. студії. - 2019. - 13, № 1.
|
| 16. |
Hiyama T. Eradication Therapy of Helicobacter pylori for low - Grade Mucosa - Associated Lymphoid Tissue Lymphomas of the Stomach. — 2000 // Эксперим. онкология.
|
| 17. |
Samanta S. Evaluation of Napro-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a rationally designed mixed-function anticancer agent. — 2001 // Эксперим. онкология.
|
| 18. |
Berezhnaya N. M. Experimental immunotherapy of mice with transplanted MC-rhabdomyosarcoma resistant to doxorubicin. — 2004 // Эксперим. онкология.
|
| 19. |
Grigorovich S. A. Factors supporting survival in multidrug resistant lymphoblast cell line IM-9/ER. — 2001 // Эксперим. онкология.
|
| 20. |
Kozak O. V. First treatment activity and outcome of radioiodine therapy in thyroid cancer patients with metastases in lymph nodes: mathematical correlation and clinical implications. — 2006 // Эксперим. онкология.
|
| | |
НОВІ
ПОШУК
Книжкові видання та компакт-диски
